Athersys, Inc.

About Athersys, Inc.

Athersys, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies to extend and enhance the quality of human life. Their mission centers on addressing significant clinical needs through regenerative medicine, particularly in the treatment of neurological, inflammatory, immune, and cardiovascular diseases, as well as other critical care conditions.

Products & Services

MultiStem:A patented, adult-derived 'off-the-shelf' stem cell therapy platform targeting disease indications in neurological, inflammatory & immune, and cardiovascular areas, as well as other critical care conditions with unmet medical needs.

Specialties

Regenerative Medicine Stem Cell Therapy Neurological Diseases Inflammatory & Immune Diseases Cardiovascular Diseases Critical Care Indications

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 3500000 MR: - FA: $3.5 million FAN: 3500000	D: 2023-08-17 FD: 2023-08-17	-
2	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 3700000 MR: - FA: 3.7 million FAN: 3700000	D: 2023-04-19 FD: 2023-04-19	-
3	RT: Registered Direct Offering and Private Placement T: - FT: Registered Direct Offering and Private Placement	A: 3700000 MR: - FA: approximately $3.7 million FAN: 3700000	D: 2023-04-18 FD: 2023-04-18	-

Public Offering Latest

2023-08-17

$3.5M

Registered Direct Offering and Private Placement 2023-04-19

$3.7M

Registered Direct Offering and Private Placement 2023-04-18

$3.7M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tirth T. Patel

Investor Relations Contact

Recent News

Athersys, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised